Cargando…
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: a protocol of a META-epidemiological study
BACKGROUND: The coronavirus disease 19 (covid-19) pandemic has underscored the need to expedite clinical research, which may lead investigators to shift away from measuring patient-important outcomes (PIO), limiting research applicability. We aim to investigate if randomized controlled trials (RCTs)...
Autores principales: | Jimenez-Mora, Mario A., Varela, Andrea Ramírez, Meneses-Echavez, Jose F., Bidonde, Julia, Angarita-Fonseca, Adriana, Siemieniuk, Reed A. C., Zeraatkar, Dena, Bartoszko, Jessica J., Brignardello-Petersen, Romina, Honarmand, Kimia, Rochwerg, Bram, Guyatt, Gordon, Yepes-Nuñez, Juan José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559914/ https://www.ncbi.nlm.nih.gov/pubmed/34724980 http://dx.doi.org/10.1186/s13643-021-01838-8 |
Ejemplares similares
-
Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality
por: Honarmand, Kimia, et al.
Publicado: (2021) -
Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis
por: Zeraatkar, Dena, et al.
Publicado: (2022) -
747. Antibiotic Therapy for Community-Acquired Pneumonia: A Systematic Review and Network Meta-Analysis of Randomized Trials
por: Siemieniuk, Reed, et al.
Publicado: (2018) -
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials
por: Izcovich, Ariel, et al.
Publicado: (2022) -
Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review
por: Zeraatkar, Dena, et al.
Publicado: (2022)